Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 8-K Event Results of operations · Regulation FD disclosure
  2. DEFA14A Proxy Proxy Materials
  3. DEF 14A Proxy Proxy Statement
  4. 4 Grant or award EVP, Quality & Ethics, and CPL acquired 11,826 shares (grant or award)
  5. 4 Grant or award Director acquired 8,595 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Executive or director change · Regulation FD disclosure
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Grant or award EVP, Ext Aff, GC, Corp Sec acquired 25,377 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Shares withheld for taxes President and CEO gave up 1,715 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, Business Operations gave up 739 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 818 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, Chief Strat & Dev Officer gave up 764 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP, Chief HR Officer gave up 561 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, Chief HR Officer gave up 934 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP, Corp Dev, GC & Secretary gave up 1,299 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,499 shares (to pay taxes)
  20. 4 Shares withheld for taxes President and CEO gave up 3,453 shares (to pay taxes)

Page 21 of 87 · 1,733 filings